Blood Breakthrough Could Spare Brain Cancer Patients Risky Surgery
A new technique for detecting glial tumors, including glioblastoma, through a non-invasive blood test, has been validated in a study at Imperial College London. This innovation promises to improve early detection, personalize treatment, and increase survival rates for brain tumor patients by reducing the need for risky surgical biopsies.A simple blood test could help diagnose patients with the deadliest form of brain cancer, sparing them from undergoing invasive, highly risky surgery.In a world-first, the new technique…